DALLAS (May 31, 2022)—Enhabit Home Health & Hospice, a home health and hospice care provider, announced it filed a Form 10 registration statement with the Securities and Exchange Commission (SEC) on May 25, 2022, in connection with its spin-off from Encompass Health Corporation. The spin-off is anticipated to occur on July 1, 2022, subject to various conditions. Upon completion of the spin-off, Enhabit will become an independent, publicly traded company.
WOONSOCKET, R.I. (May 31, 2022)—CVS Health recently announced the launch of CVS Health Virtual Primary Care, a new virtual care solution available through a single digital platform. The offering connects CVS Health’s services, clinical expertise, and data for a more coordinated and consumer-centric health care experience.
NASHVILLE, Tenn. (May 31, 2022)—National Seating & Mobility (NSM), a provider of comprehensive mobility solutions, has launched NSM Momentum Academy, a series of events designed to educate clinical partners, including physical therapists, occupational therapists, and other health care providers about best practices in mobility solutions and complex rehab technology (CRT).
WASHINGTON, D.C. (May 31, 2022)—UsAgainstAlzheimer’s recently announced the launch of The Brain Health Academy (BHA), a new series of free online courses designed in partnership with organizations including the Centers for Disease Control and Prevention, The American College of Lifestyle Medicine and the American Heart Association.
Uncover best practices for improving your patient experience that will reflect in your CAHPS scores, reviews and referrals.
June 28th, 2022
Sponsored by
NEW YORK (May 28, 2022)—The Visiting Nurse Service of New York (VNSNY) announced that it is rebranding as VNS Health—a move that makes it easier to understand and access the full and comprehensive range of health services offered by the organization, and that better reflects its mission and focus.
Arguing for access, advancing awareness
One provider shares keys to success with telehealth
AMSTERDAM (May 24, 2022)—Philips Respironics saw a sharp increase in medical device reports (MDRs) following the company’s voluntary recall of certain CPAP, BiPAP and mechanical ventilators, the company said in a recent press release. A MDR is one of the surveillance tools the United States Food and Drug Administration (FDA) uses to monitor device performance, detect potential device-related safety issues and contribute to benefit-risk assessments of these products.